Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Cancer Letters|June 1, 2005
c-Met as a target for human cancer and characterization of inhibitors for therapeutic interventionJames G Christensen, Jon Burrows, Ravi Salgia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycinPatrick C Ma, Erik Schaefer, James G Christensen, et al.
Expert Opinion on Investigational Drugs|April 26, 2006
Sunitinib malate for the treatment of solid tumours: a review of current clinical dataRobert J Motzer, Sakina Hoosen, Carlo L Bello, et al.
BMC Cancer|October 16, 2010
Efficacy of c-Met inhibitor for advanced prostate cancerWilliam H Tu, Chunfang Zhu, Curtis Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
HGF rescues colorectal cancer cells from EGFR inhibition via MET activationDavid Liska, Chin-Tung Chen, Thomas Bachleitner-Hofmann, et al.
Cancer Letters|January 25, 2012
HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasisFarbod Shojaei, Brett H Simmons, Joseph H Lee, et al.
Cancer Research|April 12, 2013
Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic miceBarbara Sennino, Toshina Ishiguro-Oonuma, Brian J Schriver, et al.
Plos One|August 2, 2019
Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistanceMelissa Dolan, Michalis Mastri, Amanda Tracz, et al.
Pageof 13